Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years - Olliaro, P; Kuesel, A; Halleux, C; Sullivan, M; Reeder, J (Public Library of Science, 2018)